CVS Health Corp
CVS
ISIN null / Valor 548525
CVS Health Corp
UMushroom community rating:
About company
CVS Health Corp is a leading healthcare company that offers a wide range of services, including pharmacy benefits management, retail pharmacy, and healthcare clinics. The company has expanded its business through strategic acquisitions, such as Coram, Omnicare, Navarro Discount Pharmacy, and Target's pharmacies and clinics. In response to the COVID-19 pandemic, CVS has played a significant role in providing testing and vaccinations, partnering with the CDC to offer on-site vaccinations at nursing homes and assisted living facilities.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (19.10.2025):
CVS Health Corp reported its second quarter of 2025 with total revenues increasing to $98.9 billion, an 8.4% rise compared to the prior year. The company achieved a GAAP diluted EPS of $0.80 and an Adjusted EPS of $1.81, alongside generating $6.5 billion in year-to-date cash flow from operations.
Financial Performance
In the second quarter of 2025, CVS Health Corp's total revenues grew by 8.4% year-over-year to reach $98.9 billion. The GAAP diluted earnings per share (EPS) stood at $0.80, while the Adjusted EPS was reported at $1.81. The company also generated $6.5 billion in cash flow from operations for the year-to-date.
Operational Achievements
Aetna® made significant strides in care navigation, enhancing the overall healthcare experience for members. CVS Pharmacy® expanded its footprint by agreeing to acquire certain prescription files and store locations from Rite Aid, strengthening its market presence. Additionally, CVS Caremark® showcased its market-leading innovation with strong renewals and a robust sales season.
Full-Year 2025 Guidance Update
CVS Health Corp revised its full-year 2025 guidance, lowering the GAAP diluted EPS range to $3.84 to $3.94 from the previously projected $4.23 to $4.43. However, the Adjusted EPS guidance was raised to a range of $6.30 to $6.40 from $6.00 to $6.20. Furthermore, the company increased its cash flow from operations guidance to at least $7.5 billion, up from the earlier estimate of approximately $7.0 billion.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
104662 M
Market cap (USD)
6,951,683
Daily traded volume (Shares)
44.4 / 43.66
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
